Kurv Yield Premium Strategy Tesla (TSLA) ETF
TSLP
Market cap $7.56M

28.00 USD

+0.84

3.09%

At close Nov 18, 4:00 PM EST

1 day

3.09%

5 days

2.04%

1 month

31.15%

3 months

19.91%

6 months

40.99%

Year to date

-1.03%

1 year

0.79%

5 years

11.96%

10 years

11.96%

Funds holding %

of 6,704 funds

–

Analysts bullish %

Fund manager confidence

Based on 2024 Q3 regulatory filings by fund managers ($100M+ AUM)

6.09% less ownership

Funds ownership: 6.09% [Q2] → 0% (-6.09%) [Q3]

50% less funds holding

Funds holding: 2 [Q2] → 1 (-1) [Q3]

100% less capital invested

Capital invested by funds: $207K [Q2] → $48 (-$207K) [Q3]

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 1

See Fund Rankings

Research analyst outlook

We haven’t received any recent analyst ratings for TSLP.

See Analyst Rankings

Financial journalist opinion

Neutral

Business Wire

2 months ago

Kurv Announces Special Distributions

SAN FRANCISCO--(BUSINESS WIRE)--Kurv Announces Special Distributions.

Neutral

Business Wire

6 months ago

AstraZeneca unveils latest research across key respiratory and immune-mediated diseases at ATS 2024 showcasing strength of its broad pipeline and portfolio

WILMINGTON, Del.--(BUSINESS WIRE)--AstraZeneca will showcase new clinical and real-world data across its leading inhaled, biologic and early science respiratory portfolio at the American Thoracic Society (ATS) International Conference, in San Diego, CA from May 17 - 22, 2024. The company will present 59 abstracts, including 12 late-breaking posters, with a focus on unmet needs in chronic obstructive pulmonary disease (COPD), severe asthma and eosinophilic granulomatosis with polyangiitis (EGPA).

See News Rankings

Charts implemented using Lightweight Charts™

Kurv Yield Premium Strategy Tesla (TSLA) ETFTSLP Market cap $7.56M